Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-134-VI | Doxorubicin | Chemo | Chemotherapy | 0.0033105 | -0.9458 | 1.1481 | 0.2491 | 0.9132 | 0.010163 | 0.97259 |
HCC1937 | Taxol | Chemo | Chemotherapy | 0.0024514 | 0.0104 | 0.6576 | 0.2104 | 2.2541 | 0.0024561 | 0.99541 |
MDA-MB-468 | Cisplatin | Chemo | Chemotherapy | 1.2638 | -0.2866 | 0.2872 | 0.0977 | 1.4057 | 1.9559 | 0.99503 |
CAL-120 | Taxol | Chemo | Chemotherapy | 0.0028769 | -0.1987 | 0.7463 | 0.3104 | 2.6390 | 0.0032354 | 0.97877 |
MDA-MB-468 | Taxol | Chemo | Chemotherapy | 0.001354 | -0.5218 | 1.0076 | 0.5243 | 1.2795 | 0.0023644 | 0.95471 |
PDX1258 | Etoposide | Topo II | Chemotherapy | 0.31701 | -0.1807 | 0.3942 | 0.1360 | 1.0906 | 0.41876 | 0.99346 |
PDX1258 | Topotecan | Topo I | Chemotherapy | 0.013472 | -0.4565 | 0.8673 | 0.2817 | 0.8122 | 0.026852 | 0.98013 |
MDA-MB-436 | Etoposide | Topo II | Chemotherapy | 0.26013 | -0.1571 | 0.4348 | 0.0454 | 0.9014 | 0.38084 | 0.99169 |
HCC1500 | Cisplatin | Chemo | Chemotherapy | 3.4531 | 0.2076 | 0.1210 | -0.0094 | 5.0000 | 3.1071 | 0.92762 |
MDA-MB-436 | Doxorubicin | Chemo | Chemotherapy | 0.0076138 | -0.1288 | 0.7061 | 0.0611 | 1.3442 | 0.0088093 | 0.99253 |
MDA-MB-436 | Cisplatin | Chemo | Chemotherapy | 0.4173 | -0.0204 | 0.3606 | 0.0365 | 1.2366 | 0.44452 | 0.99287 |
MDA-MB-436 | Taxol | Chemo | Chemotherapy | 0.0037097 | -0.2183 | 0.7083 | 0.1530 | 3.2043 | 0.0040962 | 0.99739 |
PDX1258 | Taxol | Chemo | Chemotherapy | 0.0021522 | -0.0818 | 0.6797 | 0.2357 | 1.2501 | 0.0022935 | 0.98829 |
MDA-MB-436 | Topotecan | Topo I | Chemotherapy | 0.0059389 | -0.1398 | 0.8768 | 0.0855 | 1.0160 | 0.0074925 | 0.99666 |
HCC1500 | Doxorubicin | Chemo | Chemotherapy | 0.016258 | -0.7134 | 0.7518 | 0.1833 | 0.7212 | 0.058468 | 0.98572 |
HCC1419 | Doxorubicin | Chemo | Chemotherapy | 0.025082 | -0.4663 | 0.5904 | 0.0473 | 0.5199 | 0.10425 | 0.94593 |
HCC1419 | Taxol | Chemo | Chemotherapy | 0.0052608 | 0.2143 | 0.4700 | 0.0981 | 2.1841 | 0.0040283 | 0.97754 |
BT-549 | Cisplatin | Chemo | Chemotherapy | 1.016 | 0.0674 | 0.2835 | 0.0552 | 1.0827 | 1.0937 | 0.98489 |
BT-549 | Doxorubicin | Chemo | Chemotherapy | 0.006482 | -0.3312 | 0.7603 | 0.1972 | 1.5744 | 0.0079126 | 0.9824 |
BT-549 | Taxol | Chemo | Chemotherapy | 0.0027257 | -0.2074 | 0.6989 | 0.2304 | 1.9420 | 0.0030953 | 0.98743 |
BT-549 | Topotecan | Topo I | Chemotherapy | 0.0084727 | -0.2410 | 0.8509 | 0.2269 | 1.4734 | 0.010061 | 0.9801 |
HCC1806 | Etoposide | Topo II | Chemotherapy | 0.096233 | -0.5629 | 0.6490 | 0.2019 | 0.9767 | 0.2057 | 0.99535 |
SK-BR-3 | Etoposide | Topo II | Chemotherapy | 0.39826 | -0.3169 | 0.4040 | 0.1186 | 1.5701 | 0.532 | 0.99524 |
PDX1258 | Cisplatin | Chemo | Chemotherapy | 2.5568 | 0.3181 | 0.1555 | 0.0433 | 1.6027 | 1.5449 | 0.99079 |
HCC1419 | Topotecan | Topo I | Chemotherapy | 0.0071886 | -0.7857 | 0.9904 | 0.1711 | 0.4002 | 0.11192 | 0.94532 |